BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 28583437)

  • 1. Prediction of synergistic anti-cancer drug combinations based on drug target network and drug induced gene expression profiles.
    Li X; Xu Y; Cui H; Huang T; Wang D; Lian B; Li W; Qin G; Chen L; Xie L
    Artif Intell Med; 2017 Nov; 83():35-43. PubMed ID: 28583437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network Propagation Predicts Drug Synergy in Cancers.
    Li H; Li T; Quang D; Guan Y
    Cancer Res; 2018 Sep; 78(18):5446-5457. PubMed ID: 30054332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic Drug Combination Prediction by Integrating Multiomics Data in Deep Learning Models.
    Zhang T; Zhang L; Payne PRO; Li F
    Methods Mol Biol; 2021; 2194():223-238. PubMed ID: 32926369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNRMPACDC: computational model focused on Siamese network and random matrix projection for anticancer synergistic drug combination prediction.
    Li TH; Wang CC; Zhang L; Chen X
    Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36418927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of protein interactome networks prioritizes candidate genes with cancer signatures.
    Li Y; Sahni N; Yi S
    Oncotarget; 2016 Nov; 7(48):78841-78849. PubMed ID: 27791983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion mapping of drug targets on disease signaling network elements reveals drug combination strategies.
    Xu J; Regan-Fendt K; Deng S; Carson WE; Payne PRO; Li F
    Pac Symp Biocomput; 2018; 23():92-103. PubMed ID: 29218872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting drug synergy for precision medicine using network biology and machine learning.
    Cuvitoglu A; Zhou JX; Huang S; Isik Z
    J Bioinform Comput Biol; 2019 Apr; 17(2):1950012. PubMed ID: 31057072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico drug combination discovery for personalized cancer therapy.
    Jeon M; Kim S; Park S; Lee H; Kang J
    BMC Syst Biol; 2018 Mar; 12(Suppl 2):16. PubMed ID: 29560824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy from gene expression and network mining (SynGeNet) method predicts synergistic drug combinations for diverse melanoma genomic subtypes.
    Regan-Fendt KE; Xu J; DiVincenzo M; Duggan MC; Shakya R; Na R; Carson WE; Payne PRO; Li F
    NPJ Syst Biol Appl; 2019; 5():6. PubMed ID: 30820351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DeepSynergy: predicting anti-cancer drug synergy with Deep Learning.
    Preuer K; Lewis RPI; Hochreiter S; Bender A; Bulusu KC; Klambauer G
    Bioinformatics; 2018 May; 34(9):1538-1546. PubMed ID: 29253077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systems modelling of the EGFR-PYK2-c-Met interaction network predicts and prioritizes synergistic drug combinations for triple-negative breast cancer.
    Shin SY; Müller AK; Verma N; Lev S; Nguyen LK
    PLoS Comput Biol; 2018 Jun; 14(6):e1006192. PubMed ID: 29920512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predict effective drug combination by deep belief network and ontology fingerprints.
    Chen G; Tsoi A; Xu H; Zheng WJ
    J Biomed Inform; 2018 Sep; 85():149-154. PubMed ID: 30081101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrated framework for identification of effective and synergistic anti-cancer drug combinations.
    Sharma A; Rani R
    J Bioinform Comput Biol; 2018 Oct; 16(5):1850017. PubMed ID: 30304987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal control nodes in disease-perturbed networks as targets for combination therapy.
    Hu Y; Chen CH; Ding YY; Wen X; Wang B; Gao L; Tan K
    Nat Commun; 2019 May; 10(1):2180. PubMed ID: 31097707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Repositioning for Cancer Therapy Based on Large-Scale Drug-Induced Transcriptional Signatures.
    Lee H; Kang S; Kim W
    PLoS One; 2016; 11(3):e0150460. PubMed ID: 26954019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple gene set-based method accurately predicts the synergy of drug pairs.
    Hsu YC; Chiu YC; Chen Y; Hsiao TH; Chuang EY
    BMC Syst Biol; 2016 Aug; 10 Suppl 3(Suppl 3):66. PubMed ID: 27585722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An enhanced cascade-based deep forest model for drug combination prediction.
    Lin W; Wu L; Zhang Y; Wen Y; Yan B; Dai C; Liu K; He S; Bo X
    Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35062018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMRF-MI: integrative identification of protein interaction network by modeling the gene dependency.
    Shi X; Wang X; Shajahan A; Hilakivi-Clarke L; Clarke R; Xuan J
    BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S10. PubMed ID: 26099273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TranSynergy: Mechanism-driven interpretable deep neural network for the synergistic prediction and pathway deconvolution of drug combinations.
    Liu Q; Xie L
    PLoS Comput Biol; 2021 Feb; 17(2):e1008653. PubMed ID: 33577560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-silico Prediction of Synergistic Anti-Cancer Drug Combinations Using Multi-omics Data.
    Celebi R; Bear Don't Walk O; Movva R; Alpsoy S; Dumontier M
    Sci Rep; 2019 Jun; 9(1):8949. PubMed ID: 31222109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.